Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
1176.60
Change Change %
-9.75 -0.82%

Updated:16 Jul, 2019, 16:00 PM IST

BSE
1174.80
Change Change %
-12.00 -1.01%

Updated:16 Jul, 2019, 16:01 PM IST

Glaxosmithkline Phar's Financial Summary

View last 5 years Financial Summary

Parameter MAR'19
(₹ Cr.)
MAR'18
(₹ Cr.)
Change %
Gross Sales 3,128.53 2,895.88 8.03%
Less :Inter divisional transfers 0.00 0.00 0.00%
Less: Sales Returns 0.00 0.00 0.00%
Less: Excise 0.00 24.19 -100.00%
Net Sales 3,128.53 2,871.69 8.94%
EXPENDITURE:
Increase/Decrease in Stock 25.57 -57.94 144.12%
Raw Materials Consumed 1,327.96 1,298.69 2.25%
Power & Fuel Cost 27.94 26.44 5.68%
Employee Cost 537.20 523.40 2.64%
Other Manufacturing Expenses 115.19 110.55 4.20%
General and Administration Expenses 178.51 203.43 -12.25%
Selling and Distribution Expenses 202.81 154.38 31.37%
Miscellaneous Expenses 106.88 104.29 2.48%
Expenses Capitalised 0.00 0.00 0.00%
Total Expenditure 2,522.05 2,363.25 6.72%
PBIDT (Excl OI) 606.48 508.44 19.28%
Other Income 101.48 53.52 89.61%
Operating Profit 707.96 561.96 25.98%
Interest 0.55 0.19 193.13%
PBDT 707.41 561.77 25.92%
Depreciation 48.59 37.99 27.92%
Profit Before Taxation & Exceptional Items 658.82 523.79 25.78%
Exceptional Income / Expenses 4.89 17.80 -72.53%
Profit Before Tax 663.71 541.58 22.55%
Provision for Tax 238.35 189.60 25.71%
PAT 425.36 351.99 20.85%
Extraordinary Items 0.00 0.00 0.00%
Adj to Profit After Tax 0.00 0.00 0.00%
Profit Balance B/F 1,113.21 1,067.06 4.32%
Appropriations 1,538.57 1,419.05 8.42%
Equity Dividend (%) 200.00 350.00 -42.86%
Earnings Per Share (in ₹) 25.11 41.56 -39.58%
Book Value (in ₹) 126.47 245.56 -48.50%
Top